Medtronic MDT continues to grab headlines with respect to its Diabetes management business update. Following two back-to-back European approvals last month for its InPen smart insulin pen as well as ...

Mike Mensinger, vice president of engineering at Medtronic Diabetes, talks about how the company’s products and services help people manage diabetes to improve their lives. Medtronic is a medical ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted clearance for the Android version of the InPen app, making ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

DUBLIN, Nov. 12, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of InPen™ integrated with real-time1 Guardian Connect™ CGM data.

For the last few years, Medtronic has been on a mission to make diabetes management as hassle-free as possible, aided by a slew of buyouts, product launches and integrations and regulatory OKs. The ...

New No Fingerstick 1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System DUBLIN, May 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...

Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...

A new reusable insulin injector pen combined with a smartphone app that helps insulin-dependent diabetes patients calculate their doses and keeps track of injection data is now available in the United ...

Medtronic’s smart insulin pen doesn’t merely provide a streamlined method for managing diabetes—according to newly released data, it’s also effective at helping to regulate blood sugar levels and ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, ...